Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen
Identifieur interne : 000662 ( Main/Exploration ); précédent : 000661; suivant : 000663Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen
Auteurs : Rohan S. Ingrole [États-Unis] ; Wenqian Tao [États-Unis] ; Jatindra N. Tripathy [États-Unis] ; Harvinder S. Gill [États-Unis]Source :
- Nano LIFE [ 1793-9844 ] ; 2014.
Abstract
The 23 amino acid-long extracellular domain of the influenza virus transmembrane protein M2 (M2e) has remained highly conserved since the 1918 pandemic, and is thus considered a good candidate for development of a universal influenza A vaccine. However, M2e is poorly immunogenic. In this study we assessed the potential of increasing immunogenicity of M2e by constructing a nanoscale-designed protein polymer containing the M2e sequence and an elastin-like polypeptide (ELP) nanodomain consisting of alanine and tyrosine guest residues (ELP(A2YA2)24). The ELP nanodomain was included to increase antigen size, and to exploit the inherent thermal inverse phase transition behavior of ELPs to purify the protein polymer. The ELP(A2YA2)24 + M2e nanodomained molecule was recombinantly synthesized. Characterization of its inverse phase transition behavior demonstrated that attachment of M2e to ELP(A2YA2)24 increased its transition temperature compared to ELP(A2YA2)24. Using a dot blot test we determined that M2e conjugated to ELP is recognizable by M2e–specific antibodies, suggesting that the conjugation process does not adversely affect the immunogenic property of M2e. Further, upon vaccinating mice with ELP(A2YA2)24 + M2e it was found that indeed the nanodomained protein enhanced M2e–specific antibodies in mouse serum compared to free M2e peptide and ELP(A2YA2)24. The immune serum could also recognize M2 expressed on influenza virions. Overall, this data suggests the potential of using molecules containing M2e–ELP nano-domains to develop a universal influenza vaccine.
Url:
DOI: 10.1142/s1793984414500044
PubMed: 25825595
PubMed Central: 4376021
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000833
- to stream Pmc, to step Curation: 000833
- to stream Pmc, to step Checkpoint: 000449
- to stream Ncbi, to step Merge: 000B53
- to stream Ncbi, to step Curation: 000B53
- to stream Ncbi, to step Checkpoint: 000B53
- to stream Main, to step Merge: 000663
- to stream Main, to step Curation: 000662
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen</title>
<author><name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25825595</idno>
<idno type="pmc">4376021</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376021</idno>
<idno type="RBID">PMC:4376021</idno>
<idno type="doi">10.1142/s1793984414500044</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000833</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000833</idno>
<idno type="wicri:Area/Pmc/Curation">000833</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000833</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000449</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000449</idno>
<idno type="wicri:Area/Ncbi/Merge">000B53</idno>
<idno type="wicri:Area/Ncbi/Curation">000B53</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B53</idno>
<idno type="wicri:doubleKey">1793-9844:2014:Ingrole R:synthesis:and:immunogenicity</idno>
<idno type="wicri:Area/Main/Merge">000663</idno>
<idno type="wicri:Area/Main/Curation">000662</idno>
<idno type="wicri:Area/Main/Exploration">000662</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen</title>
<author><name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Biotechnology and Genomics Texas Tech University Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Engineering Texas Tech University, 6th and Canton Lubbock, Texas 79409</wicri:regionArea>
<wicri:noRegion>Texas 79409</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Nano LIFE</title>
<idno type="ISSN">1793-9844</idno>
<idno type="eISSN">1793-9852</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">The 23 amino acid-long extracellular domain of the influenza virus transmembrane protein M2 (M2e) has remained highly conserved since the 1918 pandemic, and is thus considered a good candidate for development of a universal influenza A vaccine. However, M2e is poorly immunogenic. In this study we assessed the potential of increasing immunogenicity of M2e by constructing a nanoscale-designed protein polymer containing the M2e sequence and an elastin-like polypeptide (ELP) nanodomain consisting of alanine and tyrosine guest residues (ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
). The ELP nanodomain was included to increase antigen size, and to exploit the inherent thermal inverse phase transition behavior of ELPs to purify the protein polymer. The ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
+ M2e nanodomained molecule was recombinantly synthesized. Characterization of its inverse phase transition behavior demonstrated that attachment of M2e to ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
increased its transition temperature compared to ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
. Using a dot blot test we determined that M2e conjugated to ELP is recognizable by M2e–specific antibodies, suggesting that the conjugation process does not adversely affect the immunogenic property of M2e. Further, upon vaccinating mice with ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
+ M2e it was found that indeed the nanodomained protein enhanced M2e–specific antibodies in mouse serum compared to free M2e peptide and ELP(A<sub>2</sub>
YA<sub>2</sub>
)<sub>24</sub>
. The immune serum could also recognize M2 expressed on influenza virions. Overall, this data suggests the potential of using molecules containing M2e–ELP nano-domains to develop a universal influenza vaccine.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Ingrole, Rohan S" sort="Ingrole, Rohan S" uniqKey="Ingrole R" first="Rohan S." last="Ingrole">Rohan S. Ingrole</name>
</noRegion>
<name sortKey="Gill, Harvinder S" sort="Gill, Harvinder S" uniqKey="Gill H" first="Harvinder S." last="Gill">Harvinder S. Gill</name>
<name sortKey="Tao, Wenqian" sort="Tao, Wenqian" uniqKey="Tao W" first="Wenqian" last="Tao">Wenqian Tao</name>
<name sortKey="Tripathy, Jatindra N" sort="Tripathy, Jatindra N" uniqKey="Tripathy J" first="Jatindra N." last="Tripathy">Jatindra N. Tripathy</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000662 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000662 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:4376021 |texte= Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25825595" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
This area was generated with Dilib version V0.6.33. |